234 related articles for article (PubMed ID: 14585933)
1. Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.
Woo MH; Losasso C; Guo H; Pattarello L; Benedetti P; Bjornsti MA
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13767-72. PubMed ID: 14585933
[TBL] [Abstract][Full Text] [Related]
2. Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the N terminus in clamp closure.
Palle K; Pattarello L; van der Merwe M; Losasso C; Benedetti P; Bjornsti MA
J Biol Chem; 2008 Oct; 283(41):27767-27775. PubMed ID: 18693244
[TBL] [Abstract][Full Text] [Related]
3. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
[TBL] [Abstract][Full Text] [Related]
4. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
[TBL] [Abstract][Full Text] [Related]
6. Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae.
Sloan R; Huang SN; Pommier Y; Jinks-Robertson S
DNA Repair (Amst); 2017 Nov; 59():69-75. PubMed ID: 28961461
[TBL] [Abstract][Full Text] [Related]
7. Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.
Pouliot JJ; Robertson CA; Nash HA
Genes Cells; 2001 Aug; 6(8):677-87. PubMed ID: 11532027
[TBL] [Abstract][Full Text] [Related]
8. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
Vance JR; Wilson TE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13669-74. PubMed ID: 12368472
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of DNA topoisomerase I-induced cell killing in the yeast Saccharomyces cerevisiae.
Fiorani P; Bjornsti MA
Ann N Y Acad Sci; 2000; 922():65-75. PubMed ID: 11193926
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.
Knab AM; Fertala J; Bjornsti MA
J Biol Chem; 1993 Oct; 268(30):22322-30. PubMed ID: 8226741
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
12. The role of topoisomerase I in suppressing genome instability associated with a highly transcribed guanine-rich sequence is not restricted to preventing RNA:DNA hybrid accumulation.
Yadav P; Owiti N; Kim N
Nucleic Acids Res; 2016 Jan; 44(2):718-29. PubMed ID: 26527723
[TBL] [Abstract][Full Text] [Related]
13. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
Laco GS; Collins JR; Luke BT; Kroth H; Sayer JM; Jerina DM; Pommier Y
Biochemistry; 2002 Feb; 41(5):1428-35. PubMed ID: 11814334
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.
van der Merwe M; Bjornsti MA
J Biol Chem; 2008 Feb; 283(6):3305-3315. PubMed ID: 18056711
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase I (TOP1) dynamics: conformational transition from open to closed states.
Takahashi DT; Gadelle D; Agama K; Kiselev E; Zhang H; Yab E; Petrella S; Forterre P; Pommier Y; Mayer C
Nat Commun; 2022 Jan; 13(1):59. PubMed ID: 35013228
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives.
Laco GS
PLoS One; 2011; 6(8):e24314. PubMed ID: 21912628
[TBL] [Abstract][Full Text] [Related]
17. Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate.
Fertala J; Vance JR; Pourquier P; Pommier Y; Bjornsti MA
J Biol Chem; 2000 May; 275(20):15246-53. PubMed ID: 10809761
[TBL] [Abstract][Full Text] [Related]
18. Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiae.
Lebedeva N; Auffret Vander Kemp P; Bjornsti MA; Lavrik O; Boiteux S
DNA Repair (Amst); 2006 Jul; 5(7):799-809. PubMed ID: 16713756
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies.
Laco GS; Du W; Kohlhagen G; Sayer JM; Jerina DM; Burke TG; Curran DP; Pommier Y
Bioorg Med Chem; 2004 Oct; 12(19):5225-35. PubMed ID: 15351405
[TBL] [Abstract][Full Text] [Related]
20. Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality.
Losasso C; Cretaio E; Palle K; Pattarello L; Bjornsti MA; Benedetti P
J Biol Chem; 2007 Mar; 282(13):9855-9864. PubMed ID: 17276985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
